The global chiral chromatography column market size was evaluated at $110.9 million in 2022 and is slated to hit $190.7 million by the end of 2030 with a CAGR of nearly 7.01% between 2023 and 2030.
The development of chromatography instrument technology and the importance of chromatography-based research in medication approval are the main drivers driving the market for chiral chromatography columns. Increased government funding, subsidies, and expenditures have pushed the biotechnology and pharmaceutical industries to adopt the cutting-edge chromatographic technique driving the market's expansion.
Four phthalimide-analog thalidomide derivatives, for example, were successfully separated through enantioseparation in a polar organic mobile phase mode, according to a report published by the Multidisciplinary Digital Publishing Institute in December 2021 on five distinct polysaccharide-type chiral selectors.
This finding raises the possibility of a new kind of chiral screening technique. Because of this, novel approaches to drug molecule analysis can be found using chiral chromatography, and this is anticipated to propel market expansion.
Additionally, it is anticipated that recent partnerships and acquisitions by the big companies will benefit the market. For example, in February 2022, Sartorius completed the acquisition of the Novasep chromatography division after the US Federal Trade Commission gave its clearance.
The portfolio that was purchased includes cutting-edge equipment for the continuous production of biologics along with chromatography systems that are mostly appropriate for smaller biomolecules like insulin, peptides, and oligonucleotides. Therefore, it is anticipated that the studied market will be strongly driven by the aforementioned variables.
However, it is anticipated that the equipment's growing cost may impede market expansion.
The market outlook portion of the study primarily covers the fundamental dynamics of the market, including the industry's opportunities, challenges, drivers, and constraints. While opportunities and challenges are external market elements, drivers and restrictions are intrinsic ones.
The growing uses of chiral chromatography in biotechnology, pharmaceuticals, and other industries is what is primarily driving the global market for chiral chromatography columns. Furthermore, the market for chiral chromatography columns is expanding due to the growing significance of chromatography studies in the approval of medications and significant investments made in research and development by life science companies.
The industry is expanding even faster thanks to increased government funding for clinical research projects and sophisticated chiral chromatography technique advancements. Conversely, the factors that could limit market expansion are the high cost of chromatography equipment and the need for experienced personnel to operate such expensive machinery.
uses primary sources to filter the available data, validate the information, and then compile it into a comprehensive market research study. The report includes an evaluation of market factors that the client is interested in, both quantitatively and qualitatively. The "Global Chiral Chromatography Column Market" is primarily divided into smaller divisions that offer categorised information about the most recent market trends.
Global Chiral Chromatography Column Market: Competitive Players
The global chiral chromatography column market is led by players like:
- Phenomenex
- Agilent Technologies
- Sigma-Aldrich Co
- Thermo Fisher Scientific Inc
- GE Healthcare
- Shimadzu Corporation
- Waters Corporation
The global chiral chromatography column market is segmented as follows:
By Type
- Pre-Packed Columns
- Empty Columns
By Application
- Thin Layer Chromatography Systems
- Supercritical Fluid Chromatography
- Liquid Chromatography Systems
- Gas Chromatography Systems
By Materials
- Glass
- Metal
- Plastic
By End User
- Food Beverage Industry
- Hospitals/Clinic
- Nutraceutical Companies
- Environmental Agencies
- Pharmaceutical Biotechnology Industry
- Cosmetic Industry
- Government Laboratories
- Research Institutes
Global Chiral Chromatography Column Market: Regional Segment Analysis
- North America U.S.
- Europe UK France Germany
- Asia Pacific China Japan India
- Latin America Brazil
- The Middle East and Africa
Overview of the Chiral Chromatography Columns Industry
There are a few significant players in the somewhat competitive market for chiral chromatography columns. Right now, a small number of very large companies control the majority of the market share. A few well-known companies are actively acquiring other businesses and launching new products in order to strengthen their market positions globally.
Present market leaders include Merck KGaA, Thermo Fisher Scientific Inc., Daicel Corporation, Shimadzu Corporation, Bio-Rad Laboratories, Danaher Corporation (Phenomenex Inc.), General Electric Company (GE Healthcare), and Agilent Technologies.
Market News for Chiral Chromatography Columns
September 2022 saw the introduction of the Octave BIO Multi-Column Chromatography (MCC) system by Tosoh Bioscience, a supplier of chromatographic solutions for the purification and separation of biomolecules. With the help of the system and the pre-packed columns from SkillPak BIO, customers may create pre-clinical processes fast and effectively.
In June 2022, EconoFit Low-Pressure Prepacked Chromatography Column Packs were introduced by Bio-Rad Laboratories Inc. to facilitate resin screening tests related to the creation of protein purification workflows.
Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651
Newark: 1 (302) 444-0166
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
